Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Knowledge of viral hepatitis among Puerto Rican adults: implications for prevention.

Soto-Salgado M, Suárez E, Ortiz AP, Adrovet S, Marrero E, Meléndez M, Colón HM, Albizu C, Del C Santos M, Torres E, Pérez CM.

J Community Health. 2011 Aug;36(4):565-73. doi: 10.1007/s10900-010-9342-6.

2.
3.

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.

BMC Public Health. 2011 May 19;11:351. doi: 10.1186/1471-2458-11-351.

4.

Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico.

Pérez CM, Marrero E, Meléndez M, Adrovet S, Colón H, Ortiz AP, Soto-Salgado M, Albizu C, Torres EA, Suárez E.

BMC Infect Dis. 2010 Mar 23;10:76. doi: 10.1186/1471-2334-10-76.

5.

Surveillance for acute viral hepatitis - United States, 2007.

Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2009 May 22;58(3):1-27.

6.

Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.

Shapiro AJ, Esther CR, Leigh MW, Dellon EP.

Vaccine. 2013 Jan 30;31(6):906-11. doi: 10.1016/j.vaccine.2012.12.004. Epub 2012 Dec 20.

PMID:
23261047
7.

Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.

Gutiérrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer Ríos MT, Sousa Martín JM, Sayago Mota M, Giráldez Gallego A, Suárez Artacho G.

Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.

PMID:
22841196
8.
9.
10.

Predictors of hepatitis knowledge improvement among methadone maintained clients enrolled in a hepatitis intervention program.

Nyamathi A, Tyler D, Sinha K, Marfisee M, Cohen A, Greengold B.

J Community Health. 2010 Aug;35(4):423-32. doi: 10.1007/s10900-010-9266-1.

11.

Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.

Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH.

Vaccine. 2015 Jun 4;33(24):2808-12. doi: 10.1016/j.vaccine.2015.04.019. Epub 2015 Apr 15.

PMID:
25889161
12.

Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China.

Yu L, Wang J, Zhu D, Leng A, Wangen KR.

Hum Vaccin Immunother. 2016;12(1):70-6. doi: 10.1080/21645515.2015.1069932. Epub 2015 Jul 25.

13.

Prevention of Liver Cancer Through the Early Detection of Risk-related Behavior Among Hepatitis B or C Carriers.

Fan JY, Huang TJ, Jane SW, Chen MY.

Cancer Nurs. 2015 May-Jun;38(3):169-76. doi: 10.1097/NCC.0000000000000153.

PMID:
24836958
14.
15.

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.

Am J Gastroenterol. 2008 Jan;103(1):138-46. Epub 2007 Oct 26.

PMID:
17970833
16.

Hepatitis B knowledge, testing and vaccination levels in Chinese immigrants to British Columbia, Canada.

Hislop TG, Teh C, Low A, Li L, Tu SP, Yasui Y, Taylor VM.

Can J Public Health. 2007 Mar-Apr;98(2):125-9.

PMID:
17441536
17.

[Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].

Chlíbek R, Smetana J, Sindelár R, Cecetková B, Prymula R, Kohl I.

Epidemiol Mikrobiol Imunol. 2007 Aug;56(3):119-28. Czech.

PMID:
17900060
18.

Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: a systematic review.

Shah HA, Abu-Amara M.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):922-33. doi: 10.1016/j.cgh.2013.04.024. Epub 2013 Apr 29. Review.

PMID:
23639601
19.

[Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].

de Artaza Varasa T, Sánchez Ruano JJ, García Vela A, Gómez Rodríguez R, Romero Gutiérrez M, de la Cruz Pérez G, Gómez Moreno AZ, Carrobles Jiménez JM.

Gastroenterol Hepatol. 2009 Aug-Sep;32(7):483-8. doi: 10.1016/j.gastrohep.2009.03.009. Epub 2009 Jul 3. Spanish.

PMID:
19577338
20.

The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.

Jakiche R, Borrego ME, Raisch DW, Gupchup GV, Pai MA, Jakiche A.

Am J Med Sci. 2007 Jan;333(1):26-34.

PMID:
17220691

Supplemental Content

Support Center